More US mass tort litigation is to be expected. This is what the predictions by Praedicat show. Today, opioid-related claims are up on the agenda with a potential bill of up to USD 864 billion. But there is likely more to come: from sugar to bisphenol A substitutes and a whole range of other chemicals and ingredients. Praedicat also shows that there is meanwhile a huge gap in coverage of insurable risks.
We will discuss the mechanics of US product liability litigation at our Casualty Day on 10 October in Dusseldorf. Find out more here.

/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-02-23-17-17-30-948-699c8baa10483a0eee366517.jpg)
/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-02-19-10-36-56-727-6996e7c85e7746f10b76648d.jpg)
/Passle/59994aefb00e801a0c1447be/SearchServiceImages/2026-02-09-10-17-10-869-6989b426d736d254086c16a7.jpg)